Bone lead levels are associated with measures of memory impairment in older adults

NeuroToxicology

Volumn 30, Issue 4, 2009, Pages 572-580

  van Wijngaarden, Edwin ^a   Campbell, James R ^a   Cory Slechta, Deborah A ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Aging; Bone lead; Epidemiology; K XRF; Memory disorders; Mild cognitive impairment

Indexed keywords

LEAD;

ADULT; AGE; AGED; ALZHEIMER DISEASE; ANAMNESIS; ARTICLE; BONE LEVEL; CALCANEUS; CLINICAL ARTICLE; COGNITIVE DEFECT; DEMENTIA; EDUCATION; FEMALE; HUMAN; HYPERTENSION; LEARNING; MALE; MEMORY DISORDER; NEUROPSYCHOLOGICAL TEST; PILOT STUDY; PRIORITY JOURNAL; SCORING SYSTEM; SMOKING; STATISTICAL ANALYSIS; TIBIA; X RAY FLUORESCENCE;

AGED; ALZHEIMER DISEASE; BONE AND BONES; COGNITION DISORDERS; FEMALE; GERIATRIC ASSESSMENT; HUMANS; LEAD; LINEAR MODELS; MALE; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; X-RAYS;

EID: 67651001604     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2009.05.007     Document Type: Article

References (45)

1. Ahamed M., and Siddiqui M.K. Low level lead exposure and oxidative stress: current opinions. Clin Chim Acta 383 (2007) 57-64
2. Alzheimer's Association. 2008 Alzheimer's disease facts and figures. Alzheimers Dement 4 (2008) 110-133
3. Aro A., Amarasiriwardena C., Lee M.L., Kim R., and Hu H. Validation of K X-ray fluorescence bone lead measurements by inductively coupled plasma mass spectrometry in cadaver legs. Med Phys 27 (2000) 119-123
4. Barbeau E., Didic M., Tramoni E., Felician O., Joubert S., Sontheimer A., et al. Evaluation of visual recognition memory in MCI patients. Neurology 62 (2004) 1317-1322
5. Basha M.R., Murali M., Siddiqi H.K., Ghosal K., Siddiqi O.K., Lashuel H.A., et al. Lead (Pb) exposure and its effect on APP proteolysis and Abeta aggregation. FASEB J 19 (2005) 2083-2084
6. Basha M.R., Wei W., Bakheet S.A., Benitez N., Siddiqi H.K., Ge Y.W., et al. The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain. J Neurosci 25 (2005) 823-829
7. Bolin C.M., Basha R., Cox D., Zawia N.H., Maloney B., Lahiri D.K., et al. Exposure to lead and the developmental origin of oxidative DNA damage in the aging brain. FASEB J 20 (2006) 788-790
8. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Survey Data (2007), U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA
9. Chertkow H. Diagnosis and treatment of dementia: introduction. Introducing a series based on the third Canadian consensus conference on the diagnosis and treatment of dementia. CMAJ 178 (2008) 316-321
10. Chertkow H., Massoud F., Nasreddine Z., Belleville S., Joanette Y., Bocti C., et al. Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia. CMAJ 178 (2008) 1273-1285
11. Christoffersson J.O., Schutz A., Ahlgren L., Haeger-Aronsen B., Mattsson S., and Skerfving S. Lead in finger-bone analysed in vivo in active and retired lead workers. Am J Ind Med 6 (1984) 447-457
12. Egerhazi A., Berecz R., Bartok E., and Degrell I. Automated neuropsychological test battery (CANTAB) in mild cognitive impairment and in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 746-751
13. Gerhardsson L., Attewell R., Chettle D.R., Englyst V., Lundstrom N.G., Nordberg G.F., et al. In vivo measurements of lead in bone in long-term exposed lead smelter workers. Arch Environ Health 48 (1993) 147-156
14. In: Glantz S.A. (Ed). A primer of biostatistics. 5th ed. (2002), McGraw-Hill, New York, NY
15. Hu H., Milder F.L., and Burger D.E. X-ray fluorescence measurements of lead burden in subjects with low-level community lead exposure. Arch Environ Health 45 (1990) 335-341
16. Hu H., Payton M., Korrick S., Aro A., Sparrow D., Weiss S.T., et al. Determinants of bone and blood lead levels among community-exposed middle-aged to elderly men. The normative aging study. Am J Epidemiol 144 (1996) 749-759
17. Hu H., Pepper L., and Goldman R. Effect of repeated occupational exposure to lead, cessation of exposure, and chelation on levels of lead in bone. Am J Ind Med 20 (1991) 723-735
18. Hu H., Rabinowitz M., and Smith D. Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environ Health Perspect 106 (1998) 1-8
19. Iddon J.L., Pickard J.D., Cross J.J., Griffiths P.D., Czosnyka M., and Sahakian B.J. Specific patterns of cognitive impairment in patients with idiopathic normal pressure hydrocephalus and Alzheimer's disease: a pilot study. J Neurol Neurosurg Psychiatry 67 (1999) 723-732
20. Kim R., Aro A., Rotnitzky A., Amarasiriwardena C., and Hu H. K X-ray fluorescence measurements of bone lead concentration: the analysis of low-level data. Phys Med Biol 40 (1995) 1475-1485
21. Lanphear B.P., Hornung R., Khoury J., Yolton K., Baghurst P., Bellinger D.C., et al. Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect 113 (2005) 894-899
22. Muldoon S.B., Cauley J.A., Kuller L.H., Morrow L., Needleman H.L., Scott J., et al. Effects of blood lead levels on cognitive function of older women. Neuroepidemiology 15 (1996) 62-72
23. Nasreddine Z.S., Phillips N.A., Bedirian V., Charbonneau S., Whitehead V., Collin I., et al. The Montreal Cognitive Assessment. MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53 (2005) 695-699
24. Navas-Acien A., Guallar E., Silbergeld E.K., and Rothenberg S.J. Lead exposure and cardiovascular disease-a systematic review. Environ Health Perspect 115 (2007) 472-482
25. Patterson C., Feightner J.W., Garcia A., Hsiung G.Y., MacKnight C., and Sadovnick A.D. Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease. CMAJ 178 (2008) 548-556
26. Perlstein T., Weuve J., Schwartz J., Sparrow D., Wright R., Litonjua A., et al. Cumulative community-level lead exposure and pulse pressure: the normative aging study. Environ Health Perspect 115 (2007) 1696-1700
27. Perneger T.V. What's wrong with Bonferroni adjustments. BMJ 316 (1998) 1236-1238
28. Pratico D. Oxidative stress hypothesis in Alzheimer's disease: a reappraisal. Trends Pharmacol Sci 29 (2008) 609-615
29. Rajan P., Kelsey K.T., Schwartz J.D., Bellinger D.C., Weuve J., Spiro III A., et al. Interaction of the delta-aminolevulinic acid dehydratase polymorphism and lead burden on cognitive function: the VA normative aging study. J Occup Environ Med 50 (2008) 1053-1061
30. Reddy G.R., Devi B.C., and Chetty C.S. Developmental lead neurotoxicity: alterations in brain cholinergic system. Neurotoxicology 28 (2007) 402-407
31. Robbins T.W., James M., Owen A.M., Sahakian B.J., McInnes L., and Rabbitt P. Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia 5 (1994) 266-281
32. Shih R.A., Hu H., Weisskopf M.G., and Schwartz B.S. Cumulative lead dose and cognitive function in adults: a review of studies that measured both blood lead and bone lead. Environ Health Perspect 115 (2007) 483-492
33. Smith T., Gildeh N., and Holmes C. The Montreal Cognitive Assessment: validity and utility in a memory clinic setting. Can J Psychiatry 52 (2007) 329-332
34. Somervaille L.J., Chettle D.R., Scott M.C., Tennant D.R., McKiernan M.J., Skilbeck A., et al. In vivo tibia lead measurements as an index of cumulative exposure in occupationally exposed subjects. Br J Ind Med 45 (1988) 174-181
35. Theppeang K., Glass T.A., Bandeen-Roche K., Todd A.C., Rohde C.A., Links J.M., et al. Associations of bone mineral density and lead levels in blood, tibia, and patella in urban-dwelling women. Environ Health Perspect 116 (2008) 784-790
36. Vaziri N.D. Mechanisms of lead-induced hypertension and cardiovascular disease. Am J Physiol Heart Circ Physiol 295 (2008) H454-H465
37. Vaziri N.D., and Gonick H.C. Cardiovascular effects of lead exposure. Indian J Med Res 128 (2008) 426-435
38. 2+ on muscarinic modulation of glutamatergic synaptic transmission in rat hippocampal CA1 area. Neurotoxicology 28 (2007) 499-507
39. Weisskopf M.G., Proctor S.P., Wright R.O., Schwartz J., Spiro III A., Sparrow D., et al. Cumulative lead exposure and cognitive performance among elderly men. Epidemiology 18 (2007) 59-66
40. Weisskopf M.G., Wright R.O., Schwartz J., Spiro III A., Sparrow D., Aro A., et al. Cumulative lead exposure and prospective change in cognition among elderly men: the VA Normative Aging Study. Am J Epidemiol 160 (2004) 1184-1193
41. Weuve J., Korrick S.A., Weisskopf M.A., Ryan L.M., Schwartz J., Nie H., et al. Cumulative exposure to lead in relation to cognitive function in older women. Environ Health Perspect 117 (2009) 574-580
42. White L.D., Cory-Slechta D.A., Gilbert M.E., Tiffany-Castiglioni E., Zawia N.H., Virgolini M., et al. New and evolving concepts in the neurotoxicology of lead. Toxicol Appl Pharmacol 225 (2007) 1-27
43. Wright R.O., Tsaih S.W., Schwartz J., Spiro III A., McDonald K., Weiss S.T., et al. Lead exposure biomarkers and mini-mental status exam scores in older men. Epidemiology 14 (2003) 713-718
44. Wu J., Basha M.R., Brock B., Cox D.P., Cardozo-Pelaez F., McPherson C.A., et al. Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD. J Neurosci 28 (2008) 3-9
45. Wu J., Basha M.R., and Zawia N.H. The environment, epigenetics and amyloidogenesis. J Mol Neurosci 34 (2008) 1-7